Earnings calls

Clean Science concall ledger

Every earnings call for CLEAN — management tone, guidance, KPIs and promise tracking, quarter by quarter.

CLEAN · 7 transcripts · Chemicals · latest Q4 FY26

Q4 FY26Published 14 May 2026Call held 14 May 2026

CLEAN Q4 FY26 Earnings Call Transcript & Analysis

Standalone Revenue₹193 cr−19% YoYStandalone EBITDA₹88 crStandalone EBITDA Margin46%Standalone PAT₹77 cr

Standalone Revenue (Q4 FY26) ₹193 cr (−19% YoY); Standalone EBITDA (Q4 FY26) ₹88 cr; Standalone EBITDA Margin (Q4 FY26) 46%. Q4 FY26 standalone revenue improved 8% Q-o-Q to INR 193 crores.

Read full transcript & analysis

Q3 FY26Published 31 Jan 2026Call held 31 Jan 2026

CLEAN Q3 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹216 cr−21% YoYConsolidated EBITDA Margin33%Consolidated PAT Margin21%

Consolidated Revenue ₹216 cr (−21% YoY); Consolidated EBITDA Margin 33%; Consolidated PAT Margin 21%. Stand-alone revenue moderated to ₹180 crores.

Read full transcript & analysis

Q2 FY26Published 06 Nov 2025Call held 06 Nov 2025

CLEAN Q2 FY26 Earnings Call Transcript & Analysis

Standalone Revenue₹206 cr−8% YoYStandalone EBITDA₹90 cr−5% YoYStandalone EBITDA Margin44%+2% YoYStandalone PAT₹65 cr−4% YoY

Standalone Revenue ₹206 cr (−8% YoY); Standalone EBITDA ₹90 cr (−5% YoY); Standalone EBITDA Margin 44% (+2% YoY). Standalone revenue decreased 5% QoQ to INR 206 crores and 8% YoY.

Read full transcript & analysis

Q1 FY26Published 17 Jul 2025Call held 17 Jul 2025

CLEAN Q1 FY26 Earnings Call Transcript & Analysis

Standalone Revenue₹217 crStandalone EBITDA₹101 crStandalone EBITDA Margin46%Standalone PAT₹77 cr

Standalone Revenue ₹217 cr; Standalone EBITDA ₹101 cr; Standalone EBITDA Margin 46%. Standalone Revenue decreased by 9% sequentially to INR217 crores.

Read full transcript & analysis

Q1 FY26Published 17 Jul 2025Call held 17 Jul 2025

CLEAN Q1 FY26 Earnings Call Transcript & Analysis

Standalone Revenue₹217 crStandalone EBITDA₹101 crStandalone EBITDA Margin46.54%Standalone PAT₹77 cr

Standalone Revenue ₹217 cr; Standalone EBITDA ₹101 cr; Standalone EBITDA Margin 46.54%. Standalone EBITDA margin reached a record high of over 46%.

Read full transcript & analysis

Q3 FY25Published 30 Jan 2025Call held 30 Jan 2025

CLEAN Q3 FY25 Earnings Call Transcript & Analysis

Consolidated EBITDA₹98 cr+14% YoYConsolidated EBITDA Margin41.5%Consolidated PAT₹66 cr+5% YoY

Consolidated EBITDA ₹98 cr (+14% YoY); Consolidated EBITDA Margin 41.5%; Consolidated PAT ₹66 cr (+5% YoY). Consolidated Sales: ₹240 crores, up 23% YoY and steady QoQ.

Read full transcript & analysis

Q2 FY25Published 07 Nov 2024Call held 07 Nov 2024

CLEAN Q2 FY25 Earnings Call Transcript & Analysis

EBITDA₹95 cr+25% YoYEBITDA Margin42%

EBITDA ₹95 cr (+25% YoY); EBITDA Margin 42%. EBITDA remained steady at INR95 crores, with strong EBITDA margins of 42% in Q2 FY25.

Read full transcript & analysis